Long Progression-free Survival with Afatinib in a Patient with EGFR-unknown Lung Adenocarcinoma after Erlotinib Failure: A Case ReportMaria Giuseppa Vitale, Giacomo Cartenl, Ferdinando Riccardi et al.|Tumori Journal|2015Cited by 2